1. |
Vestbo J, Hurd SS, Agusti AG, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med, 2013, 187:347-365.
|
2. |
Usmani OS. Small airways dysfunction in asthma: evaluation and management to improve asthma control. Allergy Asthma Immunol Res, 2014, 6:376.
|
3. |
Hogg JC, Macklem PT, Thurlbeck WM. Site and nature of airway obstruction in chronic obstructive lung disease.NEngl J Med, 1968, 278:1355-1360.
|
4. |
Patel BD, Coxson HO, Pillai SG, et al. Airway wall thickening and emphysema show independent familial aggregation in chronic obstructive pulmonary disease. Am J Respir Crit Care Med, 2008, 178:500-505.
|
5. |
Contoli M, Bousquet J, Fabbri LM, et al. The small airways and distal lung compartment in asthma and COPD:atime for reappraisal. Allergy, 2010, 65:141-151.
|
6. |
Mineshita M, Shikama Y, Nakajima H, et al. The application of impulse oscillation system for the evaluation of treatment effects in patients with COPD. Respir Physiol Neurobiol, 2014, 202:1-5.
|
7. |
Han MK, Agusti A, Calverley PM, et al. Chronic obstructive pulmonary disease phenotypes: the future of COPD. Am J Respir Crit Care Med, 2010, 182:598-604.
|
8. |
中华医学会呼吸病学分会慢性阻塞性肺疾病学组.慢性阻塞性肺疾病诊治指南(2013年修订版).中华结核和呼吸杂志, 2013, 36:1-10.
|
9. |
Oostveen E, MacLeod D, Lorino H, et al. The forced oscillation technique in clinical practice: methodology, recommendations and future developments. Eur Respir J, 2003, 22:1026-1041.
|
10. |
Laszlo G. Standardisation of lung function testing: helpful guidance from the ATS/ERS Task Force. Thorax, 2006, 61:744-746.
|
11. |
Hasegawa M, Nasuhara Y, Onodera Y, et al. Airflow limitation and airway dimensions in chronic obstructive pulmonary disease. Am J Respir Crit Care Med, 2006, 173:1309-1315.
|
12. |
Kitaguchi Y, Fujimoto K, Kubo K, et al. Characteristics of COPD phenotypes classified according to the findings of HRCT. Respir Med, 2006, 100:1742-1752.
|
13. |
Timmins SC, Coatsworth N, Palnitkar G, et al. Day-to-day variability of oscillatory impedance and spirometry in asthma and COPD. Respir Physiol Neurobiol, 2013, 185:416-424.
|
14. |
Verbanck S. Physiological measurement of the small airways. Respiration, 2012, 84:177-188.
|
15. |
张洪波, 林耀广, 林江涛, 等.脉冲振荡响应频率检测小气道功能障碍的应用价值.中日友好医院学报, 2002, Z1:271-273.
|
16. |
Pisi R, Aiello M, Zanini A, et al. Small airway dysfunction and flow and volume bronchodilator responsiveness in patients with chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis, 2015, 10:1191-1197.
|
17. |
McDonough JE, Yuan R, Suzuki M, et al. Small-airway obstruction and emphysema in chronic obstructive pulmonary disease.NEnglJMed, 2011, 365:1567-1575.
|
18. |
Nakano Y, Wong JC, de Jong PA, et al. The prediction of small airway dimensions using computed tomography. Am J Respir Crit Care Med, 2005, 171:142-146.
|
19. |
Kanda S, Fujimoto K, Komatsu Y, et al. Evaluation of respiratory impedance in asthma and COPD by an impulse oscillation system. Intern Med, 2010, 49:23-30.
|
20. |
Burgel PR. The role of small airways in obstructive airway diseases. Eur Respir Rev, 2011, 20:23-33.
|